OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Targeting epigenetics and non-coding RNAs in atherosclerosis: from mechanisms to therapeutics
Suowen Xu, Danielle Kamato, Peter J. Little, et al.
Pharmacology & Therapeutics (2018) Vol. 196, pp. 15-43
Open Access | Times Cited: 138

Showing 1-25 of 138 citing articles:

Endothelial Dysfunction in Atherosclerotic Cardiovascular Diseases and Beyond: From Mechanism to Pharmacotherapies
Suowen Xu, Iqra Ilyas, Peter J. Little, et al.
Pharmacological Reviews (2021) Vol. 73, Iss. 3, pp. 924-967
Open Access | Times Cited: 667

The sirtuin family in health and disease
Qi‐Jun Wu, Tie‐Ning Zhang, Huanhuan Chen, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 398

Berberine in Cardiovascular and Metabolic Diseases: From Mechanisms to Therapeutics
Xiaojun Feng, Antoni Sureda, Samineh Jafari, et al.
Theranostics (2019) Vol. 9, Iss. 7, pp. 1923-1951
Open Access | Times Cited: 322

Liver Macrophages: Old Dogmas and New Insights
Adrien Guillot, Frank Tacke
Hepatology Communications (2019) Vol. 3, Iss. 6, pp. 730-743
Open Access | Times Cited: 286

Curcumin, the golden spice in treating cardiovascular diseases
Hong Li, Antoni Sureda, Hari Prasad Devkota, et al.
Biotechnology Advances (2019) Vol. 38, pp. 107343-107343
Closed Access | Times Cited: 278

ATP-citrate lyase (ACLY) in lipid metabolism and atherosclerosis: An updated review
Xiaojun Feng, Lei Zhang, Suowen Xu, et al.
Progress in Lipid Research (2019) Vol. 77, pp. 101006-101006
Closed Access | Times Cited: 185

Targeting Foam Cell Formation in Atherosclerosis: Therapeutic Potential of Natural Products
Dongdong Wang, Yang Yang, Yingnan Lei, et al.
Pharmacological Reviews (2019) Vol. 71, Iss. 4, pp. 596-670
Open Access | Times Cited: 173

Targeting Mechanosensitive Transcription Factors in Atherosclerosis
Niu Niu, Suowen Xu, Yanni Xu, et al.
Trends in Pharmacological Sciences (2019) Vol. 40, Iss. 4, pp. 253-266
Open Access | Times Cited: 149

Mechanisms of Oxidized LDL-Mediated Endothelial Dysfunction and Its Consequences for the Development of Atherosclerosis
Hui Jiang, Yongwen Zhou, Seyed Mohammad Nabavi, et al.
Frontiers in Cardiovascular Medicine (2022) Vol. 9
Open Access | Times Cited: 140

Foam Cells in Atherosclerosis: Novel Insights Into Its Origins, Consequences, and Molecular Mechanisms
Yuzhou Gui, Hongchao Zheng, Richard Y. Cao
Frontiers in Cardiovascular Medicine (2022) Vol. 9
Open Access | Times Cited: 137

Atherosclerosis and Inflammation: Insights from the Theory of General Pathological Processes
Evgeni Gusev, Alexey Sarapultsev
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 9, pp. 7910-7910
Open Access | Times Cited: 101

Endothelial dysfunction: molecular mechanisms and clinical implications
Xia Wang, Ben He
MedComm (2024) Vol. 5, Iss. 8
Open Access | Times Cited: 25

Rutaecarpine: A promising cardiovascular protective alkaloid from Evodia rutaecarpa (Wu Zhu Yu)
Kunming Tian, Jingjie Li, Suowen Xu
Pharmacological Research (2019) Vol. 141, pp. 541-550
Closed Access | Times Cited: 141

Knockdown of NEAT1 induces tolerogenic phenotype in dendritic cells by inhibiting activation of NLRP3 inflammasome
Maomao Zhang, Zheng Yang, Yong Sun, et al.
Theranostics (2019) Vol. 9, Iss. 12, pp. 3425-3442
Open Access | Times Cited: 111

Metformin, Macrophage Dysfunction and Atherosclerosis
Xiaojun Feng, Wenxu Chen, Xiayun Ni, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 93

Foam Cells as Therapeutic Targets in Atherosclerosis with a Focus on the Regulatory Roles of Non-Coding RNAs
Amin Javadifar, Sahar Rastgoo, Maciej Banach, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 5, pp. 2529-2529
Open Access | Times Cited: 75

Metformin in cardiovascular diabetology: a focused review of its impact on endothelial function
Yu Ding, Yongwen Zhou, Ping Ling, et al.
Theranostics (2021) Vol. 11, Iss. 19, pp. 9376-9396
Open Access | Times Cited: 66

Nanomedicine for Diagnosis and Treatment of Atherosclerosis
Jingyun Cheng, Hui Huang, Yu Chen, et al.
Advanced Science (2023) Vol. 10, Iss. 36
Open Access | Times Cited: 39

Herbal medicines provide regulation against iron overload in cardiovascular diseases: Informing future applications
Jia Liu, Liangyan Deng, Liping Qu, et al.
Journal of Ethnopharmacology (2024) Vol. 326, pp. 117941-117941
Closed Access | Times Cited: 8

Non-coding RNA in endothelial-to-mesenchymal transition
Melanie S. Hulshoff, Gonzalo del Monte‐Nieto, Jason C. Kovacic, et al.
Cardiovascular Research (2019) Vol. 115, Iss. 12, pp. 1716-1731
Open Access | Times Cited: 70

A simple protocol for isolating mouse lung endothelial cells
Jinping Wang, Niu Niu, Suowen Xu, et al.
Scientific Reports (2019) Vol. 9, Iss. 1
Open Access | Times Cited: 57

Histone methylation and vascular biology
Xiang Wei, Xin Yi, Xue‐Hai Zhu, et al.
Clinical Epigenetics (2020) Vol. 12, Iss. 1
Open Access | Times Cited: 56

Promising Directions in Atherosclerosis Treatment Based on Epigenetic Regulation Using MicroRNAs and Long Noncoding RNAs
Daria Skuratovskaia, Maria Vulf, Alexandra Komar, et al.
Biomolecules (2019) Vol. 9, Iss. 6, pp. 226-226
Open Access | Times Cited: 54

Targeting the epigenome in in-stent restenosis: from mechanisms to therapy
Xi Yang, Yanyan Yang, Junjie Guo, et al.
Molecular Therapy — Nucleic Acids (2021) Vol. 23, pp. 1136-1160
Open Access | Times Cited: 54

Page 1 - Next Page

Scroll to top